TinyGemsBreaks Archive - Page 34 of 151

WednesdayMar 19, 2025 11:02 am

TinyGemsBreaks – Authentic Holdings (OTC: AHRO) to Acquire Goliath Motion Pictures for $11 Million

Authentic Holdings (OTC: AHRO) announced its agreement to acquire Goliath Motion Pictures Entertainment in an $11 million equity-based transaction. The acquisition will bring over 40,000 titles, including award-winning shows and films such as In Living Color, The Cosby Show, and Open Range, under Authentic Holdings' ownership. The deal is structured as Convertible Preferred Stock, with conversion restrictions for three years to minimize shareholder dilution. Management expects the acquisition to strengthen Maybacks Global Entertainment’s market position, increase advertising revenue, and support expansion into all major U.S. markets. An 8-K will be filed with the SEC upon completion. To view the full…

TuesdayMar 18, 2025 10:09 am

TinyGemsBreaks – Brera Holdings PLC (NASDAQ: BREA) Sponsors ‘Pepito Day’ Honoring Giuseppe Rossi’s Football Legacy

Brera Holdings (NASDAQ: BREA), an international multi-club ownership company, has announced its sponsorship of “Pepito Day,” a tribute event celebrating the career of Giuseppe “Pepito” Rossi. Set for March 22, 2025, at Stadio Artemio Franchi in Florence, Italy, the event will bring together legendary football figures, including Sir Alex Ferguson, Gabriel Batistuta, Andrea Pirlo, and Giorgio Chiellini. Rossi, a Brera Holdings advisory board member, played a key role in Fiorentina’s history and continues to contribute to the company’s global football operations. The celebration will feature a youth tournament, meet-and-greet sessions, and a star-studded match. To view the full press release,…

FridayMar 14, 2025 3:41 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) Novel Therapies Show Promise Against Aggressive Cancers

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company that is pioneering proprietary technology designed to attack solid tumors, empowering the immune system to combat cancer. The company was featured in a recent article that discussed its platform, which utilizes antitumor virotherapies that selectively infect and kill cancer cells while stimulating the body’s immune response. Calidi’s pipeline includes three key therapies — RTNova, SuperNova and NeuroNova — that incorporate advanced technologies such as stem cells and antitumor viruses to target and destroy cancer cells. Calidi Biotherapeutics’ innovative therapies hold the potential to revolutionize cancer treatment by enhancing efficacy and stimulating…

FridayMar 14, 2025 8:30 am

TinyGemsBreaks – D-Wave Reports Fourth Quarter and Year-End 2024 Results

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has announced its financial results for fourth quarter and year-end 2024, with a 128% year-over-year increase in bookings, reaching $23.9 million in bookings for the year ended December 31, 2024. The company also announced a consolidated cash balance that now exceeds $300 million. "Every day D-Wave’s quantum technology is helping customers gain competitive advantages, discover new scientific breakthroughs, and fuel innovations that were previously unimaginable," said Dr. Alan Baratz, CEO of D-Wave. "Our mission is unwavering - to help organizations realize the benefits of quantum…

FridayMar 07, 2025 9:37 am

TinyGemsBreaks – Brera Holdings PLC (NASDAQ: BREA) Adds Economist Arthur Laffer to Advisory Board

Brera Holdings (NASDAQ: BREA) an Ireland-based international holding company focused on multi-club ownership in sports, has appointed Dr. Arthur B. Laffer to its Advisory Board. Laffer, a renowned economist known for the Laffer Curve and his work in supply-side economics, joins an existing lineup of high-profile advisors, including Massimo Ferragamo and Alan Rothenberg. His expertise in market expansion and asset monetization will support Brera’s strategy of positioning football clubs as global economic assets, with a focus on player monetization, revenue growth, and international market penetration. Laffer’s advisory role is expected to contribute to financial modeling, sponsorship opportunities, and expansion efforts…

ThursdayMar 06, 2025 10:10 am

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) to Release Full-Year 2024 Financial Results on March 17

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced it will release its financial results for the full-year ended Dec. 31, 2024, before market open on March 17, 2025. Executive Chairman and CEO Charles M. Fernandez, CFO Cecile Munnik, and President and CEO of Global Operations David Phipps will host a conference call at 8:30 a.m. Eastern to discuss the results and recent developments. To view the full press release, visit: https://ibn.fm/e55SD About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and…

WednesdayMar 05, 2025 2:44 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Stands at the Forefront of Integrating New Oncology Therapies

Calidi Biotherapeutics (NYSE American: CLDI) is leveraging innovative platforms in a commitment to transform cancer treatment using advanced biotechnology. “The company is pioneering therapies that combine stem cells with antitumor viruses to create powerful cancer treatments. Antitumor viruses or virotherapies selectively infect and destroy cancer cells while sparing normal cells and, when paired with stem cells, their therapeutic potential is significantly amplified,” reads a recent article. “Calidi’s pipeline includes the proprietary SuperNova (‘SNV’) platform, which utilizes allogeneic adipose-derived mesenchymal stem cells (‘AD-MSCs’) as carriers for antitumor virotherapy. This approach has shown promise in preclinical studies and safety studies, with potential applications…

TuesdayMar 04, 2025 9:45 am

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Advances 7.2 MW Solar Project in New York

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) has completed the Coordinated Electric System Interconnection Review for its 7.2 MW DC North Main solar project in Wyoming County, New York, allowing it to move forward with permitting. Once approved and financed, the project will proceed to construction and operate as a community solar initiative, benefiting local residents with lower electricity costs through the New York State Energy Research and Development Authority's NY-Sun Program. Solar Simplified will manage customer enrollment and subscriptions to ensure full participation and maximize revenue. To view the full press release, visit https://ibn.fm/XAzEY About…

MondayMar 03, 2025 1:10 pm

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) CEO Featured in Electrek Podcast

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., was featured in a Quick Charge podcast produced by Electrek Daily. SolarBank CEO Richard Lu joined the program and host Jo Borrás to discuss how his decades of experience led him to build a vertically integrated clean energy company, as well as provide a look at some of the opportunities that lie ahead. To view the full podcast, visit https://ibn.fm/2aXcn About SolarBank Corporation SolarBank…

FridayFeb 28, 2025 10:45 am

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) and OS Therapies (NYSE American: OSTX) to Appear on RedChip’s Bloomberg TV Show

Calidi Biotherapeutics (NYSE American: CLDI) and OS Therapies Inc. (NYSE American: OSTX) will be featured on RedChip’s Small Stocks, Big Money™ show, airing on Bloomberg TV this Saturday, March 1, at 7 p.m. ET. Andrew Jackson, CFO of Calidi, will discuss the company’s stem cell-based oncolytic virotherapy platform designed to enhance cancer treatment. Calidi’s lead candidates, CLD-101 and CLD-201, target significant market opportunities estimated between $13 billion and $15 billion in the U.S. OS Therapies CEO Paul Romness will highlight OST-HER2, an immunotherapy targeting HER2-positive osteosarcoma and solid tumors, with potential for accelerated FDA approval. The company also advances a…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks